These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 31509648)

  • 1. Treating the locoregional lymph nodes with radiation and/or surgery significantly improves outcome in dogs with high-grade mast cell tumours.
    Mendez SE; Drobatz KJ; Duda LE; White P; Kubicek L; Sorenmo KU
    Vet Comp Oncol; 2020 Jun; 18(2):239-246. PubMed ID: 31509648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiation therapy for incompletely resected canine mast cell tumors.
    LaDue T; Price GS; Dodge R; Page RL; Thrall DE
    Vet Radiol Ultrasound; 1998; 39(1):57-62. PubMed ID: 9491519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Results of radiation therapy in 19 dogs with cutaneous mast cell tumor and regional lymph node metastasis.
    Chaffin K; Thrall DE
    Vet Radiol Ultrasound; 2002; 43(4):392-5. PubMed ID: 12175005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of dogs with grade 3 mast cell tumors: 43 cases (1997-2007).
    Hume CT; Kiupel M; Rigatti L; Shofer FS; Skorupski KA; Sorenmo KU
    J Am Anim Hosp Assoc; 2011; 47(1):37-44. PubMed ID: 21164163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiation therapy for incompletely excised grade II canine mast cell tumors.
    Poirier VJ; Adams WM; Forrest LJ; Green EM; Dubielzig RR; Vail DM
    J Am Anim Hosp Assoc; 2006; 42(6):430-4. PubMed ID: 17088389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytological lymph node evaluation in dogs with mast cell tumours: association with grade and survival.
    Krick EL; Billings AP; Shofer FS; Watanabe S; Sorenmo KU
    Vet Comp Oncol; 2009 Jun; 7(2):130-8. PubMed ID: 19453367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aggressive local therapy combined with systemic chemotherapy provides long-term control in grade II stage 2 canine mast cell tumour: 21 cases (1999-2012).
    Lejeune A; Skorupski K; Frazier S; Vanhaezebrouck I; Rebhun RB; Reilly CM; Rodriguez CO
    Vet Comp Oncol; 2015 Sep; 13(3):267-80. PubMed ID: 23721492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant medical therapy provides no therapeutic benefit in the treatment of dogs with low-grade mast cell tumours and early nodal metastasis undergoing surgery.
    Marconato L; Stefanello D; Kiupel M; Finotello R; Polton G; Massari F; Ferrari R; Agnoli C; Capitani O; Giudice C; Aresu L; Vasconi ME; Rigillo A; Sabattini S
    Vet Comp Oncol; 2020 Sep; 18(3):409-415. PubMed ID: 31930651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymph node histology for the assessment of residual neoplastic disease in canine mast cell tumours: does the presence of metachromatic granules always identify mast cells?
    Ressel L; Finotello R
    Vet Comp Oncol; 2017 Dec; 15(4):1119-1121. PubMed ID: 27714908
    [No Abstract]   [Full Text] [Related]  

  • 10. Histologic grade has a higher-weighted value than nodal status as predictor of outcome in dogs with cutaneous mast cell tumours and overtly metastatic sentinel lymph nodes.
    Guerra D; Faroni E; Sabattini S; Agnoli C; Chalfon C; Stefanello D; Del Magno S; Cola V; Grieco V; Marconato L
    Vet Comp Oncol; 2022 Sep; 20(3):551-558. PubMed ID: 35195937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic impact of regional lymphadenectomy in canine stage II cutaneous mast cell tumours.
    Marconato L; Polton G; Stefanello D; Morello E; Ferrari R; Henriques J; Tortorella G; Benali SL; Bergottini R; Vasconi ME; Annoni M; Sabattini S
    Vet Comp Oncol; 2018 Dec; 16(4):580-589. PubMed ID: 30047226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of radiation therapy for incompletely resected grade-III mast cell tumors in dogs: 31 cases (1987-1998).
    Hahn KA; King GK; Carreras JK
    J Am Vet Med Assoc; 2004 Jan; 224(1):79-82. PubMed ID: 14710881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biologic behavior and prognostic factors for mast cell tumors of the canine muzzle: 24 cases (1990-2001).
    Gieger TL; Théon AP; Werner JA; McEntee MC; Rassnick KM; DeCock HE
    J Vet Intern Med; 2003; 17(5):687-92. PubMed ID: 14529136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iridium-192 interstitial brachytherapy as adjunctive treatment for canine cutaneous mast cell tumors.
    Northrup NC; Roberts RE; Harrell TW; Allen KL; Howerth EW; Gieger TL
    J Am Anim Hosp Assoc; 2004; 40(4):309-15. PubMed ID: 15238561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chlorambucil and prednisolone chemotherapy for dogs with inoperable mast cell tumours: 21 cases.
    Taylor F; Gear R; Hoather T; Dobson J
    J Small Anim Pract; 2009 Jun; 50(6):284-9. PubMed ID: 19527421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective study of radiation therapy for the treatment of grade 2 mast cell tumors in 32 dogs.
    al-Sarraf R; Mauldin GN; Patnaik AK; Meleo KA
    J Vet Intern Med; 1996; 10(6):376-8. PubMed ID: 8947870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A retrospective study on prophylactic regional lymphadenectomy versus nodal observation only in the management of dogs with stage I, completely resected, low-grade cutaneous mast cell tumors.
    Sabattini S; Kiupel M; Finotello R; Stefanello D; Faroni E; Bertazzolo W; Bonfanti U; Rigillo A; Del Magno S; Foglia A; Aresu L; Gambini M; Caniatti M; Marconato L
    BMC Vet Res; 2021 Oct; 17(1):331. PubMed ID: 34649575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Weishaar's classification system for nodal metastasis in sentinel lymph nodes: Clinical outcome in 94 dogs with mast cell tumor.
    Stefanello D; Gariboldi EM; Boracchi P; Ferrari R; Ubiali A; De Zani D; Zani DD; Grieco V; Giudice C; Recordati C; Caniatti M; Auletta L; Chiti LE
    J Vet Intern Med; 2024; 38(3):1675-1685. PubMed ID: 38426589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome and prognostic factors following adjuvant prednisone/vinblastine chemotherapy for high-risk canine mast cell tumour: 61 cases.
    Thamm DH; Turek MM; Vail DM
    J Vet Med Sci; 2006 Jun; 68(6):581-7. PubMed ID: 16820715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic value of lymph node metastasis with grade 2 MCTs in dogs: 55 cases (2001-2010).
    Baginski H; Davis G; Bastian RP
    J Am Anim Hosp Assoc; 2014; 50(2):89-95. PubMed ID: 24446400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.